Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine x HCl

EU orphan designation number: EU/3/05/288   
Active ingredient: 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine x HCl
Indication: Treatment of Huntington's disease
Sponsor: Teva GmbH
Graf-Arco-Straße 3, 89079 Ulm, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/06/2005 Orphan designation EMEA/OD/011/05 (2005)1908 of 20/06/2005
21/06/2007 Change of name and/or address of sponsor
30/07/2009 Transfer of orphan designation EMEA/OD/011/05/T/01 (2009)6043 of 24/07/2009
30/04/2013 Transfer of orphan designation EMEA/OD/011/05/T/02 (2013)2563 of 26/04/2013
22/11/2016 Transfer of orphan designation EMA/OD/011/05/T/03 (2016)7591 of 18/11/2016